These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET. Knuuti MJ; Nuutila P; Ruotsalainen U; Teräs M; Saraste M; Härkönen R; Ahonen A; Wegelius U; Haapanen A; Bergman J J Nucl Med; 1993 Dec; 34(12):2068-75. PubMed ID: 8254389 [TBL] [Abstract][Full Text] [Related]
26. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease]. vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949 [TBL] [Abstract][Full Text] [Related]
27. [Relation between myocardial perfusion, myocardial necrosis and residual glucose metabolism as a vitality parameter in the post-ischemic myocardium following coronary reperfusion]. Sochor H Acta Med Austriaca Suppl; 1989; 39():1-36. PubMed ID: 2787948 [TBL] [Abstract][Full Text] [Related]
28. Relation between the kinetics of thallium-201 in myocardial scintigraphy and myocardial metabolism in patients with acute myocardial infarction. Yamagishi H; Akioka K; Takagi M; Tanaka A; Takeuchi K; Yoshikawa J; Ochi H Heart; 1998 Jul; 80(1):28-34. PubMed ID: 9764055 [TBL] [Abstract][Full Text] [Related]
30. [Changes in myocardial Tc-99m-sestamibi uptake in asynergic territories during low-dose echo-dobutamine test]. Leoncini M; Marcucci G; Magni M; Silvestri M; Traini AM; Arena A; Mondanelli D; Giovannini T; Paoletti M; Bardazzi L; Mennuti A; Petrella A G Ital Cardiol; 1996 Nov; 26(11):1243-55. PubMed ID: 9036021 [TBL] [Abstract][Full Text] [Related]
31. Myocardial beta-adrenoceptor density and plasma catecholamines in syndrome X. Rosen SD; Boyd H; Rhodes CG; Kaski JC; Camici PG Am J Cardiol; 1996 Jul; 78(1):37-42. PubMed ID: 8712115 [TBL] [Abstract][Full Text] [Related]
32. Mechanisms of angina pectoris in syndrome X assessed by myocardial perfusion dynamics and heart rate variability. Meeder JG; Blanksma PK; Crijns HJ; Anthonio RL; Pruim J; Brouwer J; de Jong RM; van der Wall EE; Vaalburg W; Lie KI Eur Heart J; 1995 Nov; 16(11):1571-7. PubMed ID: 8881850 [TBL] [Abstract][Full Text] [Related]
33. Coronary autoregulation is abnormal in syndrome X: insights using myocardial contrast echocardiography. Rinkevich D; Belcik T; Gupta NC; Cannard E; Alkayed NJ; Kaul S J Am Soc Echocardiogr; 2013 Mar; 26(3):290-6. PubMed ID: 23313388 [TBL] [Abstract][Full Text] [Related]
34. Angiographic evaluation of myocardial perfusion in patients with syndrome X. Atmaca Y; Ozdemir AO; Ozdol C; Oguz D; Gulec S; Kumbasar D; Erol C Am J Cardiol; 2005 Sep; 96(6):803-5. PubMed ID: 16169365 [TBL] [Abstract][Full Text] [Related]
35. Angina with normal coronary arteries: diagnosis, pathophysiology and treatment. Chierchia SL; Fragasso G Eur Heart J; 1996 Dec; 17 Suppl G():14-9. PubMed ID: 8960450 [TBL] [Abstract][Full Text] [Related]
36. Perfusion abnormality, normal coronaries, and chest pain. Pennell DJ J Am Coll Cardiol; 2008 Jan; 51(4):473-5. PubMed ID: 18222359 [No Abstract] [Full Text] [Related]
39. Ionophoric action on the cellular membrane as a pathophysiological mechanism in syndrome X: myth or reality? Waldenström A; Ronquist G J Intern Med; 1995 Sep; 238(3):187-9. PubMed ID: 7673847 [No Abstract] [Full Text] [Related]
40. Abnormal myocardial glucose handling in patients with syndrome X: effect of beta-adrenergic blockade. Fragasso G; Chierchia SL; Rossetti E; Landoni C; Lucignani G; Fazio F G Ital Cardiol; 1997 Nov; 27(11):1113-20. PubMed ID: 9419821 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]